Bioavailability Enhancement Market Projects CAGR of 11%
Since more biopharmaceutics classification system- BCS II as well as BCS IV molecules are being evaluated in the early stages of development, one of...
Booming Performance By The Life Sciences Biz In Wales
Office for Life Sciences - OLS numbers, which were released on December 1, 2022, and cover data till the end of the financial year...
Hong Kong Gives $500mn Funding For Chinese Drug Development
The Hong Kong government announced plans to add $500 million to the Chinese Medicine Development Fund beginning with this fiscal year during a budget...
Germany Rolls First CAR-T Push For Muscle Inflammation Cure
One of the university hospitals in Germany was the first in the world to effectively treat a patient with a severe case of muscular...
More Monitoring Required of Institutional Review Boards
The Government Accountability Office has issued an analysis suggesting that the FDA should increase its oversight of institutional review boards (IRBs) to better protect...
Stroke Patients To Get A Relief With Spinal Cord Stimulation
A small clinical trial has suggested that spinal cord stimulation may help stroke patients regain movement in their limbs and hands. In an article...
Major Trial Reveals Simplified HIV Treatment Options Perfect
As per the results of international research, which has the distinction of being the world’s first study into second-line human immunodeficiency virus- HIV therapy,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...